Three mechanistic explanations, not mutually exclusive: Signalling cascade persistence: BPC-157 activates VEGFR2 and FAK-paxillin pathways whose downstream effects (angiogenesis, fibroblast migration, collagen remodelling) unfold over days to weeks after initial receptor engagement
However, to date, oligonucleotide therapeutics are still facing some technological obstacles, such as how to achieve efficient oligonucleotide delivery to target organs or tissues, how to overcome off-target interactions [4952], and how to address the sequence- and chemistry-dependent toxicity and saturation of endogenous RNA processing pathways [53, 54]
Content is approved under Practice Plus Groups clinical governance framework
JV: Conceptualization, Data curation, Investigation, Writing original draft
Monitor Progress: Keep track of your horses healing and any changes in behavior or health
Apr 14, 2023 Does Medicare Cover Ilumya